MarketsHighSingle-sourceAccelerating
7.1
BioXcel Therapeutics files for bankruptcy and enters material definitive agreement
SEC EDGAR 8-K FilingsLO·US·about 12 hours ago
Sangamo Therapeutics has filed an 8-K disclosing entry into a material definitive agreement alongside a bankruptcy or receivership filing. The specific terms of the restructuring or liquidation remain unclear, signaling significant financial distress for the biotechnology firm.